Join the following companies for their satellite symposia at ECIO 2025 to stay up to date on the latest industry developments!
Satellite symposia
Sunday, April 13
12:30 – 13:15: AstraZeneca
SY 131 – Advancing patient care for embolisation-eligible HCC: emerging treatments and future outlook
13:15 – 14:00: Canon Medical Systems Europe
SY 132 – Superpower for all: the Alphenix 4DCT
Monday, April 14
12:30 – 13:15: Boston Scientific
SY 231 – Redefining liver cancer care for 20 years and beyond
13:15 – 14:00: Terumo Interventional Systems
SY 232 – Opening new TACE horizons
14:00 – 14:45: Siemens Healthineers
SY 233 – Cracking the code: what can we do about reablation rates?
Tuesday, April 15
12:30 – 13:15: Guerbet
SY 331 – TACE in HCC management: a multifaceted approach
13:15 – 14:00: Histosonics
SY 332 – Histotripsy for the treatment of liver tumors: mechanism of action and early clinical experience
14:00 – 14:25: Medtronic
SY 333 – To be determined